𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer: results and open issues

✍ Scribed by K. Bencardino; M. Manzoni; S. Delfanti; A. Riccardi; M. Danova; G. R. Corazza


Book ID
107481001
Publisher
Springer Milan
Year
2007
Tongue
English
Weight
117 KB
Volume
2
Category
Article
ISSN
1828-0447

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Trying to compose the puzzle with all th
✍ Massimo Di Maio; Cesare Gridelli; Nicola Normanno; Francesco Perrone; Fortunato πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 162 KB

## Abstract Small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have shown promising activity in patients with non‐small cell lung cancer (NSCLC). Gefitinib has been the first of these drugs to be licensed for third‐line treatment of advanced NSCLC patients. Mor